Application Nr Approved Date Route Status External Links
ANDA203148 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications & Usage Rivastigmine Tartrate Is An Acetylcholinesterase Inhibitor Indicated For Treatment Of: • Mild-To-Moderate Dementia Of The Alzheimers Type (Ad) ( 1.1 ) • Mild-To-Moderate Dementia Associated With Parkinsons Disease (Pd) ( 1.2 ) 1.1 Alzheimer's Disease Rivastigmine Tartrate Capsules Are Indicated For The Treatment Of Mild-To-Moderate Dementia Of The Alzheimer's Type (Ad). 1.2 Parkinson's Disease Dementia Rivastigmine Tartrate Capsules Are Indicated For The Treatment Of Mild-To-Moderate Dementia Associated With Parkinson's Disease (Pd).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Rivastigmine Tartrate RIVASTIGMINE TARTRATE ZINC895301

Comments